Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL

por Rikhof, B, van der Graaf, W T A, Meijer, C, Le, P T K, Meersma, G J, de Jong, S, Fletcher, J A, Suurmeijer, A J H
Publicado 2008